The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 460.00
Ask: 470.00
Change: -4.00 (-0.85%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 465.00
Low: 458.00
Prev. Close: 469.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Apr 2023 10:55

RNS Number : 1569V
Aquis Exchange PLC
03 April 2023
 

3 April 2023

Aquis Exchange PLC

("Aquis" or the "Company")

Director/PDMR Shareholding

Aquis Exchange PLC (AQX.L), the creator and facilitator of next-generation financial markets, has been notified that Glenn Collinson, Independent Non-Executive Chairman of the Company, has purchased a total of 7,500 ordinary shares in the Company ("Ordinary Shares") on 31 March 2023 at an average price of £4.00 per Ordinary Share.

Following this, Glenn Collinson now holds 19,503 Ordinary Shares in the Company, representing 0.07% of the Company's issued share capital.

Enquiries:

Aquis Exchange PLC

Tel: +44 (0) 20 3597 6321

Alasdair Haynes, CEO

 

Richard Fisher, CFO

 

Adele Gilbert, Head of Marketing

 

 

VSA Capital Limited (AQSE Corporate Adviser)

Tel: +44(0)20 3005 5000

Andrew Raca

 

 

Liberum Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 3100 2000

Chris Clarke

 

Clayton Bush

 

Edward Thomas

 

Kane Collings

 

 

 

Canaccord Genuity Limited (Joint Broker)

Tel: +44 (0) 20 7523 8000

Emma Gabriel

 

Patrick Dolaghan

 

 

 

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Josh Royston

aquis@almapr.co.uk

Kieran Breheny

Pippa Crabtree

 

 

Notes to Editors

About Aquis Exchange PLC

Aquis Exchange PLC ("Aquis") is a creator and facilitator of next-generation financial markets, through the provision of accessible, simple and efficient stock exchanges, trading venues and technology.

 

Aquis consists of three divisions: Aquis Markets, a subscription-based exchange offering pan-European cash equities trading; Aquis Technologies, which develops and licenses next-generation exchange technology globally; and Aquis Stock Exchange, a growth and regulated primary exchange delivering capital to companies via the listing and trading of shares.

 

Aquis Markets operates lit and dark order books, covering 16 European markets. For its lit books, Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on Aquis than other trading venues in Europe.

 

Aquis Technologies is the software and technology division of Aquis. It focuses on building better markets via the creation and licensing of cutting-edge, cost-effective exchange infrastructure technology and services, including matching engine and trade surveillance solutions.

 

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

 

Aquis is authorised and regulated by the UK Financial Conduct Authority and France's Autorité de contrôle prudentiel et de résolution and Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK & Switzerland markets and in EU27 markets respectively. Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu.

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Glenn Collinson

2

Reason for the notification

 

a)

Position/status

 

Independent Non-Executive Chairman

b)

Initial notification/ Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Aquis Exchange plc

b)

LEI

 

213800IXJSF5E1SIW150

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 10 pence each

 

ISIN: GB00BD5JNK30

b)

Nature of the transaction

 

Purchase of shares

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£4.00

4,997

£3.99

2,503

 

d)

Aggregated information

- Aggregated volume

- Price

 

7,500 Ordinary Shares purchased at an average price of £3.9666 for consideration of £29,974.97 on 31 March 2023

e)

Date of the transaction

 

31 March 2023

f)

Place of the transaction 

On market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFSASTIVIIV
Date   Source Headline
18th Apr 20242:30 pmRNSResult of AGM and Confirmation of Board Change
22nd Mar 20247:00 amRNSPublication of Annual Report and Notice of AGM
21st Mar 20247:00 amRNSResults for the year ended 31 December 2023
13th Mar 20247:00 amRNSContract with the Central Bank of Colombia
12th Mar 20247:00 amRNSAquis to Establish New Real Assets Market Segment
26th Feb 20247:00 amRNSAquis launches conditional order functionality
23rd Feb 20247:00 amRNSNotice of Results and Investor Presentation
25th Jan 20247:00 amRNSTrading Update and Notice of Results
23rd Jan 20243:15 pmRNSExercise of Share Options and Total Voting Rights
21st Dec 20231:15 pmRNSDirector/PDMR Notification
29th Nov 20237:00 amRNSAQSE becomes first cloud-based RIE
24th Nov 202312:00 pmRNSDirector/PDMR Notification
2nd Nov 20237:00 amRNSHolding(s) in Company
31st Oct 202311:55 amRNSBoard Change
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 202312:39 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSInterim Results
12th Sep 20237:00 amRNSAquis Markets - Change to Proprietary Trading Rule
7th Sep 20237:00 amRNSNotice of Results and Investor Presentation
6th Sep 20237:00 amRNSAppointment of Nominated Adviser and Joint Broker
7th Aug 20232:15 pmRNSAcquisition of Minority Interest
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAquis launches Dark to Lit Sweep
27th Apr 20237:00 amRNSDirector/PDMR Notification and Issue of Options
25th Apr 20232:18 pmRNSResult of AGM
14th Apr 20237:00 amRNSPublication of Annual Report & Notice of AGM
6th Apr 20231:05 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 202310:55 amRNSDirector/PDMR Shareholding
3rd Apr 20237:01 amRNSDirector/PDMR Shareholdings
3rd Apr 20237:00 amRNSAquis Launches The World’s First 24x7 Exchange
30th Mar 20237:00 amRNSFinal Results
22nd Feb 20237:00 amRNSNotice of Results and Investor Presentation
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSTrading Update and Notice of Results
5th Jan 20237:00 amRNSDirectorate Change
12th Dec 20227:00 amRNSIG Expands UK Trading Offering With AQSE Stocks
24th Nov 20229:13 amRNSDirector/PDMR Notification
23rd Nov 20224:09 pmRNSDirector/PDMR Notification
2nd Nov 20227:00 amRNSNotice of Capital Markets Day
27th Sep 20227:00 amRNSNotice of Capital Markets Day
22nd Sep 20227:00 amRNSInterim Results
5th Sep 202212:00 pmRNSLaunch of new EU dark pool, Aquis Matching Pool
23rd Aug 20227:00 amRNSNotice of Results
6th Jul 202212:00 pmRNSAPEX stocks now trading on Hargreaves Lansdown
30th Jun 202212:49 pmRNSDirector/PDMR Notification and Issue of Options
23rd Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 202212:30 pmRNSExercise of Share Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.